---
title: "Hydromorphone Hydrochloride Injection (Dilaudid) Shortage: Availability Updates and Manufacturer Status"
summary: "The FDA has updated the shortage status for Hydromorphone Hydrochloride Injection, noting that while some strengths remain available, several presentations are currently backordered."
category: "drug-shortages"
tags: ["drug-shortage","fda","medication","Hydromorphone","Injection"]
location: "United States"
severity: "medium"
sourceUrl: "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
sourceAgency: "FDA"
publishedAt: 2026-02-11T19:10:54.000Z
---
## What's in Shortage

Hydromorphone Hydrochloride Injection, also known by the brand name Dilaudid, is currently listed in a shortage status by the FDA. This medication belongs to the Analgesia/Addiction therapeutic category and is provided in an injection dosage form. The shortage was first posted on November 1, 2017, and was most recently updated on February 5, 2026.

## Which Manufacturers Are Affected

The following manufacturers have reported varying levels of availability for Hydromorphone Hydrochloride Injection:

### Fresenius Kabi USA, LLC
**Contact:** 888-386-1300

*   **Available:**
    *   Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) — Note: Check wholesalers for inventory.
    *   Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50) — Note: Check wholesalers for inventory.
*   **Unavailable:**
    *   Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25) — Next release expected March 2026.
    *   Dilaudid, Injection, 1 mg/1 mL (NDCs 76045-009-11, 76045-009-06) — Next release expected February 2026.
    *   Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25) — Next release not available at this time.
    *   Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) — Next release not available at this time.
    *   Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10) — Next release not available at this time.
    *   Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDCs 63323-851-10, 63323-851-15) — Next release not available at this time.

### Teva Pharmaceuticals USA, Inc.
**Contact:** 800-545-8800

*   **Available:**
    *   Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDCs 0703-0018-01, 0703-0110-03, 0703-0113-03).

## Why There's a Shortage

The FDA source data does not provide a specific reason for the current shortage of Hydromorphone Hydrochloride Injection.

## What Patients Should Do

Patients who rely on this medication should be aware that while some concentrations are unavailable, others remain in supply. If you are affected by this shortage:

*   Consult with your healthcare provider or pharmacist regarding your treatment plan.
*   Ask your pharmacist to check with various wholesalers for existing inventory.
*   Contact the manufacturers directly using the phone numbers provided above for the most recent updates on specific product availability.

*Disclaimer: Patients should always consult their healthcare provider for medical advice and treatment options.*

## Source

Information provided by the FDA Drug Shortage Database.